Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Boundless Bio Q3 2026 Results: Net Loss of $5.36M, Loss Narrows

Boundless Bio, Inc. has entered into a definitive merger agreement with Serapha Bio, Inc., which will result in significant ownership dilution for existing stockholders and a potential reverse stock split. The company remains a clinical-stage biopharmaceutical firm with no revenue, a limited operating history, and expectations of continued significant operating losses as it develops its extrachromosomal DNA (ecDNA) directed therapeutic candidates.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Net income-5.4-13.9
EPS (diluted, $ a share)$-0.23$-0.62

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Source

10-Q filed with the SEC, NASDAQ: BOLD. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Boundless Bio, Inc.: key numbers

Share price
$2.41Close, Nov 16
Market cap
$56.9M
Shares outstanding
23.61MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Boundless Bio, Inc.

All →
6:14 PM ET Form 4
Insider Buying

Boundless Bio 10% Owner Kevin Tang Buys $20.1K of Stock

Kevin Tang, 10% Owner, bought 8,390 shares of Boundless Bio, Inc. at $2.40 a share, worth $20.1K in total on Nov 5, 2026. Shares held after the trade: 3,033,618 (+0.3%).

Value
$20.1K
Shares
8,390
Price
$2.40
Role
10% Owner
Holding change
+0.3%
Trade date
Nov 5, 2026
6:21 PM ET Form 4
Insider Buying

Boundless Bio 10% Owner Kevin Tang Buys $25.7K of Stock

Kevin Tang, 10% Owner, bought 10,707 shares of Boundless Bio, Inc. at $2.40 a share, worth $25.7K in total on Oct 27, 2026. Shares held after the trade: 3,022,456 (+0.4%).

Value
$25.7K
Shares
10,707
Price
$2.40
Role
10% Owner
Holding change
+0.4%
Trade date
Oct 27, 2026
4:51 PM ET Form 4
Insider Buying

Boundless Bio 10% Owner Kevin Tang Buys $51.6K of Stock

Kevin Tang, 10% Owner, bought 21,640 shares of Boundless Bio, Inc. at $2.38 to $2.40 a share (average $2.39) in 3 transactions, worth $51.6K in total between Oct 22, 2026 and Oct 26, 2026. Shares held after the trade: 3,011,749 (+0.3%).

Value
$51.6K
Shares
21,640
Average price
$2.39
Role
10% Owner
Holding change
+0.3%
Trade date
Oct 22, 2026 to Oct 26, 2026
5:49 PM ET Form 4
Insider Buying

Boundless Bio 10% Owner Kevin Tang Buys $349K of Stock

Kevin Tang, 10% Owner, bought 149,254 shares of Boundless Bio, Inc. at $2.33 to $2.34 a share (average $2.34) in 3 transactions, worth $349K in total between Oct 16, 2026 and Oct 19, 2026. Shares held after the trade: 2,989,889 (+0.6%).

Value
$349K
Shares
149,254
Average price
$2.34
Role
10% Owner
Holding change
+0.6%
Trade date
Oct 16, 2026 to Oct 19, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.